DALLAS - March. 1, 2016 - A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose ...
Injection of a new long-acting insulin combined with another drug improves glucose control in patients with type 2 diabetes and, additionally, is associated with weight loss, a multinational clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results